Skip to Main Content
Important Announcement: We have transitioned to a new library system and updated e-resource login process. Click
here to start using the new system. Contact us with any questions at
330-325-6600 or e-mail
library@neomed.edu for help.
Breast cancer
- Comparing trastuzumab to bevacizumab for the treatment of breast cancer
- Zoledronate versus ibandronate for the treatment of breast cancer
- Anastrozole versus tamoxifen for the treatment of breast cancer
- Letrozole versus tamoxifen for treating breast cancer
- Letrozole versus anastrozole for treating breast cancer
Accelerated approval for new cancer drugs
- Vemurafenib (formerly PLX4032) for treating metastatic melanoma. Find one randomized control trial comparing this drug to another drug. For your second article, find an article testing PLX4032 on cancer cell lines. Choose a review article of your choice.
- Crizotinib for treating non-small cell lung cancer. See H. McEwen about the choosing your articles.
Melanoma
- Ipilimumab and sargramostim compared to ipilimumab for treating metastatic melanoma
- Nivolumab vs ipilimumab for treating melanoma
- Nivolumab vs Ipilimumab vs Nivolumab and Ipilimumab for treating advanced melanoma
- Vemurafenib vs dabrafenib vs trametinib for treating metastatic melanoma